VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Alcolase

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 84 out of 100

The world's first enzyme supplement developed for alcohol intolerance

Also known as Alcolase ApS

  • Biotech & therapeutics
  • Care delivery & digital health
  • Health IT
Headquarters
Copenhagen, Denmark
Founded
2020
Customers
people worldwide living with alcohol intolerance
Legal name
Alcolase ApS
Claim, correct or request removal

Record updated 28 September 2026

About

Alcolase is developing a liposomal enzyme system designed to break down alcohol in the stomach before it reaches the bloodstream.

Funding snapshot

Total raised
$1.7MSum of rounds, as of 2026-09-17Source (opens in a new tab)
Latest round
Undisclosed, $1.7M2026-05

Funding rounds

Round, 2026
$1.7M2026-05, Company stated

Products

Other
Alcolase
Web
liposomal enzyme system
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy